Stocks and Investing Stocks and Investing
Wed, May 15, 2024

Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, May 15th, 2024


Published on 2024-10-28 11:22:04 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy and Held Target at $15 on, May 15th, 2024.

Andrew has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Edward Tenthoff of "Piper Sandler" Reiterated at Buy and Held Target at $13 on, Wednesday, April 3rd, 2024
Contributing Sources